|
In 1961 Janssen Pharmaceutica joined the Johnson
& Johnson group of companies. With more than
80 drugs to its name, Janssen is one of the most
innovative pharmaceutical companies in the world
and its products have found major applications
in human medicine. In Belgium alone, the company
employs over 3700 people, more than a third of
whom are graduates.
The company's worldwide research and development
centre, the Johnson & Johnson Pharmaceutical
Research Development is conducting research and
development into a wide range of human disorders,
including mental illness, neurological disorders,
anaesthesia and analgesia, gastrointestinal disorders,
fungal infection, allergies and cancer.
Over the past years the department Animal
Health has developed into an autonomous company.
Janssen Animal Health concentrates on the development,
licensing and marketing of different drugs for
animals. For more information on the Janssen Animal
Health drugs, you can explore the following English
web site: http://www.janssenanimalhealth.be
The department Plant
& Material Protection concentrates on
the development and sales of products intended
for a wide range of diseases in plants, as well
as products for material protection. For more
information you can explore the following English
web site: http://www.janssenpharmaceutica.be/pmp
|
